| 1 |
Gehrig SM, Mihaylova V, Frese S, Mueller SM, Ligon-Auer M, Spengler CM, Petersen JA, Lundby C, Jung HH. Altered skeletal muscle (mitochondrial) properties in patients with mitochondrial DNA single deletion myopathy. Orphanet J Rare Dis 2016;11:105. [PMID: 27473873 DOI: 10.1186/s13023-016-0488-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 2 |
Chiodo A. Acquired myopathy/dystrophies. PM R 2013;5:S74-80. [PMID: 23584160 DOI: 10.1016/j.pmrj.2013.04.004] [Reference Citation Analysis]
|
| 3 |
. Current world literature. Curr Opin Neurol 2011;24:511-6. [PMID: 21900773 DOI: 10.1097/WCO.0b013e32834be5c1] [Reference Citation Analysis]
|
| 4 |
Murphy MP, Hartley RC. Mitochondria as a therapeutic target for common pathologies. Nat Rev Drug Discov 2018;17:865-86. [PMID: 30393373 DOI: 10.1038/nrd.2018.174] [Cited by in Crossref: 211] [Cited by in F6Publishing: 203] [Article Influence: 52.8] [Reference Citation Analysis]
|
| 5 |
Pfeffer G, Horvath R, Klopstock T, Mootha VK, Suomalainen A, Koene S, Hirano M, Zeviani M, Bindoff LA, Yu-Wai-Man P, Hanna M, Carelli V, McFarland R, Majamaa K, Turnbull DM, Smeitink J, Chinnery PF. New treatments for mitochondrial disease-no time to drop our standards. Nat Rev Neurol 2013;9:474-81. [PMID: 23817350 DOI: 10.1038/nrneurol.2013.129] [Cited by in Crossref: 120] [Cited by in F6Publishing: 103] [Article Influence: 13.3] [Reference Citation Analysis]
|
| 6 |
Pfeffer G, Majamaa K, Turnbull DM, Thorburn D, Chinnery PF. Treatment for mitochondrial disorders. Cochrane Database Syst Rev 2012;:CD004426. [PMID: 22513923 DOI: 10.1002/14651858.CD004426.pub3] [Cited by in Crossref: 79] [Cited by in F6Publishing: 105] [Article Influence: 7.9] [Reference Citation Analysis]
|
| 7 |
Li Z, Shen J, Liang J. Scoliosis in mitochondrial myopathy: case report and review of the literature. Medicine (Baltimore) 2015;94:e513. [PMID: 25674747 DOI: 10.1097/MD.0000000000000513] [Cited by in Crossref: 7] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Hoffmann A, Spengler D. The Mitochondrion as Potential Interface in Early-Life Stress Brain Programming. Front Behav Neurosci 2018;12:306. [PMID: 30574076 DOI: 10.3389/fnbeh.2018.00306] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 9 |
Quinzii CM, Hirano M. Primary and secondary CoQ(10) deficiencies in humans. Biofactors 2011;37:361-5. [PMID: 21990098 DOI: 10.1002/biof.155] [Cited by in Crossref: 73] [Cited by in F6Publishing: 67] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 10 |
Pfeffer G, Chinnery PF. Diagnosis and treatment of mitochondrial myopathies. Ann Med 2013;45:4-16. [PMID: 21867371 DOI: 10.3109/07853890.2011.605389] [Cited by in Crossref: 87] [Cited by in F6Publishing: 72] [Article Influence: 7.9] [Reference Citation Analysis]
|
| 11 |
Li W, Kui L, Demetrios T, Gong X, Tang M. A Glimmer of Hope: Maintain Mitochondrial Homeostasis to Mitigate Alzheimer's Disease. Aging Dis 2020;11:1260-75. [PMID: 33014536 DOI: 10.14336/AD.2020.0105] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
